Variable | Poor treatment outcome n (%) | OR(95 % CI) | P |
---|---|---|---|
Agea | 29.5(IQR16-43) | 1.04(1.00–1.08) | 0.062 |
Sex | |||
Male (24) | 3(12.50) | 1 | |
Female (20) | 4(20.00) | 1.75(0.34–8.95) | 0.5 |
HIV status | |||
Negative (38) | 6(15.79) | 1 | |
Positive (6) | 1(16.67) | 1.07(0.11–10.82) | 0.95 |
Illness durationa | 18(IQR 9–32) | 0.98(0.94–1.02) | 0.49 |
Fungal growth type | |||
Yeast (21) | 2(9.52) | 1 | |
Molds (23) | 5(21.74) | 2.64(0.45–15.36) | 0.2 |